Mouse and human HSPC immobilization in liquid culture by CD43- or CD44-antibody coating

  • Dirk Loeffler
    Department of Biosystems Science and Engineering, Eidgenössische Technische Hochschule Zurich, Basel, Switzerland; and
  • Weijia Wang
    Department of Biosystems Science and Engineering, Eidgenössische Technische Hochschule Zurich, Basel, Switzerland; and
  • Alois Hopf
    Department of Biosystems Science and Engineering, Eidgenössische Technische Hochschule Zurich, Basel, Switzerland; and
  • Oliver Hilsenbeck
    Department of Biosystems Science and Engineering, Eidgenössische Technische Hochschule Zurich, Basel, Switzerland; and
  • Paul E. Bourgine
    Department of Biosystems Science and Engineering, Eidgenössische Technische Hochschule Zurich, Basel, Switzerland; and
  • Fabian Rudolf
    Department of Biosystems Science and Engineering, Eidgenössische Technische Hochschule Zurich, Basel, Switzerland; and
  • Ivan Martin
    Department of Biomedicine, University Hospital Basel/University of Basel, Basel, Switzerland
  • Timm Schroeder
    Department of Biosystems Science and Engineering, Eidgenössische Technische Hochschule Zurich, Basel, Switzerland; and

この論文をさがす

説明

<jats:title>Key Points</jats:title> <jats:p>Anti-CD43– and anti-CD44–antibody coating immobilizes live mouse and human HSPCs. This enables 2D colony formation, medium exchange without cell-identification loss, and increased throughput of time-lapse imaging.</jats:p>

収録刊行物

  • Blood

    Blood 131 (13), 1425-1429, 2018-03-29

    American Society of Hematology

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ